Takeda Pharmaceutical Company Limited
More Than 15 Years Experience: Takeda Marks one Billion Treatment Courses of Gastric Ulcer Drug Pantoprazole
Zurich (ots/PRNewswire) - ? Takeda Pharmaceuticals International GmbH ("Takeda") today announced that over one billion treatment courses of its gastrointestinal product pantoprazole have been administered around the world.[1] Initially launched in 1994 in Germany, pantoprazole, a proton pump inhibitor (PPI) used to ...